The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays: A Post-hoc Analysis

Thromb Haemost. 2022 Dec;122(12):2045-2049. doi: 10.1055/a-1926-2367. Epub 2022 Aug 17.

Authors

Lauré M Fijen¹, Remy S Petersen¹, Joost C M Meijers^{2

3}, Laura Bordone⁴, Marcel Levi¹, Danny M Cohn¹

Affiliations

¹ Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
² Department of Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
³ Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
⁴ Ionis Pharmaceuticals, Carlsbad, California, United States.

No abstract available

MeSH terms

Blood Coagulation / genetics
Fibrinolysin
Fibrinolysis*
Humans
Oligonucleotides
Prekallikrein*
alpha-2-Antiplasmin

Substances

Prekallikrein
Oligonucleotides
Fibrinolysin
alpha-2-Antiplasmin